Places xylazine under federal drug control

Bill s545-119 ("Places xylazine under federal drug control") is before Congress and has not been decided. Latest step (April 15, 2026): Placed on Senate Legislative Calendar under General Orders. Calendar No. 372.

Congress file s545-119, before Congress. Still to be decided as of 2026-04-15.

What it does

Selling or making xylazine for street use becomes a federal crime Anyone who distributes or manufactures xylazine outside legal veterinary channels faces federal criminal penalties under the Controlled Substances Act starting upon passage.

The bigger picture

DEA can now track and block xylazine supply chains nationwide Xylazine sales are added to the DEA's national drug tracking system, giving federal agents real-time visibility into who is buying, selling, and moving the drug.

What to watch

Veterinarians and pharmacies get 60 days to register with DEA Legitimate animal doctors and pharmacies must apply for DEA registration within 60 days; those who apply during that window may keep working while the DEA processes their paperwork, but delays could disrupt animal care if approval is slow.

Official summary

This bill regulates xylazine under the Controlled Substances Act (CSA).Xylazine, also known as tranq, is a nonopioid sedative and pain reliever that is approved for use in animals. Recently, the Drug Enforcement Administration (DEA) has reported an increase in trafficking of fentanyl mixed with xylazine.This bill adds xylazine, including its salts, isomers, and salts of isomers, to schedule III of the CSA. Schedule III controlled substances, including anabolic steroids, buprenorphine, and ketamine, have less potential for abuse than a schedule I or II substance, have a currently accepted medical use, and have low or moderate risk of dependence if abused.Under the bill, manufacturing, distributing, or dispensing xylazine, or possessing with intent to manufacture, distribute, or dispense xylazine for illicit use is subject to criminal penalties under the CSA. The bill also requires xylazine transactions to be tracked in the drug reporting system maintained by the DEA.The bill exempts from registration under the CSA persons and entities that possess xylazine (1) lawfully dispensed by a veterinarian or pharmacy and (2) for an animal or for use in certain animal-control or wildlife prog

Read the official record for s545-119

See everything up for a vote · This week in Congress · See what we have filed with the clerk